| PERIOD ENDING | 31-Dec-09 | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | | Total Revenue | 959,285 | 854,625 | 869,830 | 917,568 | | Cost of Revenue | 902,835 | 808,145 | 818,621 | 854,094 | | | Gross Profit | 56,450 | 46,480 | 51,209 | 63,474 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 48,859 | 49,159 | 48,440 | 47,432 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 7,591 | (2,679) | 2,769 | 16,042 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (2,648) | 40,254 | 13,017 | 7,895 | | Earnings Before Interest And Taxes | 25,101 | 29,983 | 23,378 | 23,937 | | Interest Expense | 2,566 | 3,493 | 3,243 | 3,856 | | Income Before Tax | 22,535 | 26,490 | 20,135 | 20,081 | | Income Tax Expense | 9,972 | (9,758) | (6,425) | 3,935 | | Minority Interest | 312 | 467 | 359 | (173) | | | | Net Income From Continuing Ops | 33,033 | 36,715 | 26,919 | 15,973 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 12,875 | 36,715 | 26,919 | 15,973 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $12,875 | $36,715 | $26,919 | $15,973 |
|
0.35% Nasdaq 0.00%
Income Statement
